Health
State of Health Bharat Biotech unveils first vaccine candidate for Zika virus
04 Feb 2016, 05:59 pm Print
Hyderabad, Feb 3 (JEN): Vaccines and Bio-Therapeutic manufacturer, Bharat Biotech, on Wednesday announced breakthrough in developing world’s first, two promising candidates Zikavac vaccines for Zika infection.
Bharat Biotech claimed it began to work on the Zika Virus a year ago.
The company said it has invested over 150 million dollars since inception to build its portfolio of vaccines.
The most remarkable vaccine developments have been-
Rotavac - First vaccine from the developing world
Chikungunya Vaccine- entering Phase 1 trials shortly, first in the developing world.
Typbar TCV -Typhoid Conjugate Vaccine – successfully commercialized.
"The first thing is to be prepared for the worst," said Ella said who along with Sumathy and the R&D team at Bharat Biotech is working in the Zika vaccine program said.
More Health
- Devastating virus may threaten chocolate supply across the globe, finds study
- Saudi Arabia pledges USD 500 million for polio protection
- Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during pandemic, observes WHO
- Social media affects mental health, well-being, education of young girls, UN report shows
- New WHO report shows smoking and drinking is on the rise among teenagers in Europe, Central Asia and Canada
